DIAGNOS Announces Grant of Stock Options
BROSSARD, Quebec, April 03, 2024 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through the use of Artificial Intelligence (AI)… Read More »DIAGNOS Announces Grant of Stock Options